King Pharmaceuticals Inc.

(NYSE:KG)
  Sep 30, 2008 Jun 30, 2008
Cash Flow Statement
Cash At Beginning Of Period 20,009 20,009
Cash At End Of Period 1,231,451 1,095,549
Net Change In Cash And Cash Equivalents 1,211,442 1,075,540
Effect Of Exchange Rate Changes
Net Income Or Loss 215,404 130,654
Cash From Operating Activities
Depreciation Expenses
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables
Increase Or Decrease In Inventories
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities
Increase Or Decrease In Other Working Capital
Other Non Cash Items 134,480 107,573
Net Cash From Continuing Operations
Net Cash From Discontinued Operations 349,884 238,227
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 10,390 77
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -53,413 -39,805
Acquisitions -43 -42
Purchase Of Long Term Investments
Purchase Of Short Term Investments -279,175 -279,175
Other Investing Changes Net -6 52
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 863,583 839,162
Cash From Financing Activities
Issuance Of Debt
Issuance Of Capital Stock
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends -2,025 -1,849
Net Other Financing Charges -2,025 -1,849
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -2,025 -1,849